*** Copy and paste the following link to join remotely: https://zoom.us/j/510756428
*** Lunch will be provided.
Overland Park, KS office of IPS-Integrated Project Services, LLC presents innovative facility solutions to address the future needs of 503A & 503B Compounding Pharmacies. Pharmaceutical compounding industry has been undergoing significant changes as a result of the recent FDA and USP regulation changes. At the same time, the future of medicine points to a greater need for individualized patient solutions. Compounding industry is expected to grow in size and complexity, to fulfil the demand for custom medication.
In collaboration with BioKansas, DYNALABS, Formulet and SKAN, IPS presents an in-depth discussion on facility solutions that address compliance, safety and business concerns. The presenter information is as follows:
Moderator: Russell Odegard, CEO & Founding Partner, DYNALABS
Compliance/USP & FDA Regulations: Vince Cebular, Vice President and Principal, IPS
Facility/Design Solutions: Komal Hatti, Sr. Process Architect, IPS
Isolator Technology: Bill Friedheim, Director, Central Region, SKAN
Owner’s Concerns: Mark Spiecker, Managing Director & Founding Partner, Formulet